CARY, N.C.--(BUSINESS WIRE)--Biologics, Inc. is proud to announce that Karl Buer, Business Development, has been endorsed to lead growth initiatives in the expansion of Biologics’ Clinical Research Services while Elliott Lee has been promoted to Program Manager of the department. Buer will be responsible for leading the business development and sales initiatives while Lee will help launch and manage all programs within Clinical Research Services.
“Both Karl and Elliott have been instrumental in helping support our clinical trial partners,” said Dan Duffy, Chief Business Development Officer. “Their experience and leadership will help guide future growth and I’m thrilled for them to be taking on their new roles.”
The Clinical Research Services team currently supports over 200 protocols across 55 active clinical trials – focusing primarily in oncology. With over 15 years of experience, Biologics provides logistics and distribution management for drugs in all phases of research. Services include drug and supply procurement, patient kit design and customized accountability reporting.
Current clients include biopharma companies, contract research organizations, the National Cancer Institute (NCI) established cooperative groups and comprehensive cancer centers of excellence. As a result of the company’s excellence in distributing Neupogen – a drug vital in the bone marrow donation process, Biologics was presented with the National Marrow Donor Program Partner of the Year Award.
About Biologics: Biologics, Inc. is an oncology services company that empowers healthcare providers, payors and biopharma to optimize cancer care for the best possible outcomes – clinical, financial and emotional. Unifying fragmented healthcare services, Biologics brings efficiency and humanity to oncology care management by focusing on the patient’s best interest as the surest path to managing cost and risk. Biologics is at the center of a rapidly changing oncology environment and supports patients across all treatment modalities, while providing clinical outcomes and informatics reporting that allow for informed decision making. Since it was founded in 1994, Biologics has been dedicated to improving the lives of those fighting cancer. Privately held, Biologics maintains headquarters and operations in Cary, North Carolina.
